Total Payments
$15,360
2024 Payments
$3,147
Companies
53
Transactions
825
Medicare Patients
3,825
Medicare Billing
$386,873
Payment Breakdown by Category
Food & Beverage$15,263 (99.4%)
Education$97.20 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,263 | 822 | 99.4% |
| Education | $97.20 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,095 | 224 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,534 | 91 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,234 | 84 | $0 (2024) |
| PFIZER INC. | $956.27 | 59 | $0 (2024) |
| QOL Medical, LLC | $754.94 | 23 | $0 (2024) |
| Janssen Biotech, Inc. | $753.01 | 44 | $0 (2024) |
| GENZYME CORPORATION | $692.86 | 26 | $0 (2024) |
| Celgene Corporation | $510.85 | 32 | $0 (2024) |
| Gilead Sciences, Inc. | $377.49 | 26 | $0 (2024) |
| RedHill Biopharma Inc. | $339.12 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,147 | 140 | ABBVIE INC. ($814.37) |
| 2023 | $2,535 | 131 | AbbVie Inc. ($494.25) |
| 2022 | $2,457 | 109 | ABBVIE INC. ($852.04) |
| 2021 | $2,139 | 127 | AbbVie Inc. ($715.88) |
| 2020 | $1,028 | 61 | AbbVie Inc. ($311.31) |
| 2019 | $1,603 | 92 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($266.06) |
| 2018 | $1,579 | 105 | AbbVie, Inc. ($412.68) |
| 2017 | $872.00 | 60 | AbbVie, Inc. ($235.41) |
All Payment Transactions
825 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: VIROLOGY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.82 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/26/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $1.24 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $123.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Immunology | ||||||
| 11/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.26 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $144.48 | General |
| Category: LIVER DISEASE | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/29/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 900 | 981 | $395,099 | $91,604 |
| 2022 | 16 | 940 | 1,027 | $409,956 | $94,863 |
| 2021 | 17 | 990 | 1,088 | $435,910 | $101,018 |
| 2020 | 18 | 995 | 1,066 | $442,503 | $99,388 |
Total Patients
3,825
Total Services
4,162
Medicare Billing
$386,873
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 261 | 332 | $45,261 | $20,370 | 45.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 96 | 96 | $87,264 | $19,368 | 22.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 43 | 43 | $26,230 | $7,646 | 29.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 120 | 124 | $58,280 | $5,508 | 9.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 66 | 66 | $16,170 | $5,072 | 31.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 56 | 56 | $38,752 | $4,914 | 12.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $15,222 | $4,715 | 31.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 52 | 54 | $31,428 | $4,578 | 14.6% |
| 43238 | Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | Facility | 2023 | 27 | 28 | $25,788 | $4,225 | 16.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $10,370 | $3,065 | 29.6% |
| 91010 | Study of esophagus to assess movement | Office | 2023 | 16 | 16 | $9,088 | $2,558 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 29 | $6,262 | $2,306 | 36.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 23 | $5,014 | $2,063 | 41.1% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Office | 2023 | 16 | 16 | $8,672 | $1,951 | 22.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $7,320 | $1,708 | 23.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 26 | $3,978 | $1,558 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 276 | 357 | $49,315 | $21,265 | 43.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 96 | 96 | $87,264 | $18,759 | 21.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 77 | 77 | $53,284 | $7,438 | 14.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 127 | 131 | $61,570 | $7,387 | 12.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 57 | 57 | $20,272 | $6,047 | 29.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 32 | 32 | $19,520 | $5,608 | 28.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 72 | 72 | $17,640 | $4,994 | 28.3% |
| 43238 | Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | Facility | 2022 | 28 | 28 | $25,788 | $4,983 | 19.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 42 | 43 | $25,026 | $4,067 | 16.2% |
About Dr. Malay Dey, MD
Dr. Malay Dey, MD is a Gastroenterology healthcare provider based in Springboro, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104807155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Malay Dey, MD has received a total of $15,360 in payments from pharmaceutical and medical device companies, with $3,147 received in 2024. These payments were reported across 825 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($15,263).
As a Medicare-enrolled provider, Dey has provided services to 3,825 Medicare beneficiaries, totaling 4,162 services with total Medicare billing of $386,873. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Springboro, OH
- Active Since 11/08/2005
- Last Updated 12/03/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1104807155
Products in Payments
- XIFAXAN (Drug) $1,094
- DUPIXENT (Biological) $987.37
- XELJANZ (Drug) $863.79
- RINVOQ (Biological) $790.76
- CREON (Drug) $773.67
- STELARA (Biological) $707.02
- ZEPOSIA (Drug) $694.44
- SUCRAID (Drug) $616.24
- ENTYVIO (Biological) $597.58
- HUMIRA (Biological) $503.47
- LINZESS (Drug) $491.82
- MAVYRET (Drug) $449.03
- Humira (Biological) $408.15
- SKYRIZI (Biological) $369.84
- Talicia (Drug) $300.70
- TRULANCE (Drug) $280.21
- Trulance (Drug) $270.78
- GATTEX (Drug) $261.94
- OCALIVA (Drug) $233.03
- Creon (Drug) $220.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.